Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 1,763,756 shares at $6.71 ($11.4M) on 2024-08-27, disclosed to the SEC on 2024-08-29.
Open-market sale of $11.4M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.71 | 252,676 | $1.7M | 14.8% |
| 2 | $6.71 | 252,676 | $1.7M | 14.8% |
| 3 | $6.47 | 277,090 | $1.8M | 15.7% |
| 4 | $6.47 | 277,090 | $1.8M | 15.7% |
| 5 | $6.35 | 352,112 | $2.2M | 19.5% |
| 6 | $6.35 | 352,112 |
| $2.2M |
| 19.5% |
| Total | $6.49 avg | 1,763,756 | $11.4M | 100% |
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |